Spatial-temporal analysis of prostate cancer incidence from the Pennsylvania Cancer Registry, 2000-2011

被引:7
|
作者
Wang, Ming [1 ]
Matthews, Stephen A. [2 ,3 ]
Iskandarani, Khaled [1 ]
Li, Yimei [4 ]
Li, Zheng [1 ]
Chinchilli, Vernon M. [1 ]
Zhang, Lijun [5 ]
机构
[1] Penn State Univ, Dept Publ Hlth Sci, Hershey, PA USA
[2] Penn State Univ, Dept Sociol, University Pk, PA 16802 USA
[3] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA
[4] Univ Penn, Dept Biostat, Philadelphia, PA 19104 USA
[5] Penn State Univ, Inst Personalized Med, Hershey, PA USA
关键词
Prostate cancer; Spatial-temporal analysis; Incidence rate; Hierarchical generalised linear models; USA; RISK-FACTORS; MORTALITY; STATISTICS; DISEASE;
D O I
10.4081/gh.2017.611
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Prostate cancer is the most common cancer diagnosed among males, and the incidence in Pennsylvania, USA is considerably higher than nationally. Knowledge of regional differences and time trends in prostate cancer incidence may contribute to a better understanding of aetiologic factors and racial disparities in outcomes, and to improvements in preventive intervention and screening efforts. We used Pennsylvania Cancer Registry data on reported prostate cancer diagnoses between 2000 and 2011 to study the regional distribution and temporal trends of prostate cancer incidence in both Pennsylvania White males and Philadelphia metropolitan area Black males. For White males, we generated and mapped county-specific age-adjusted incidence and standardised incidence ratios by period cohort, and identified spatial autocorrelation and local clusters. In addition, we fitted Bayesian hierarchical generalised linear Poisson models to describe the temporal and aging effects separately in Whites state-wide and metropolitan Philadelphia blacks. Incidences of prostate cancer among white males declined from 2000-2002 to 2009-2011 with an increasing trend to some extent in the period 2006-2008 and significant variation across geographic regions, but less variation exists for metropolitan Philadelphia including majority of Black patients. No significant aging effect was detected for White and Black men, and the peak age group for prostate cancer risk varied by race. Future research should seek to identify potential social and environmental risk factors associated with geographical/racial disparities in prostate cancer. As such, there is a need for more effective surveillance so as to detect, reduce and control the cancer burden associated with prostate cancer.
引用
收藏
页码:369 / 375
页数:7
相关论文
共 50 条
  • [21] Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020
    Lei, Shaoyuan
    Zheng, Rongshou
    Zhang, Siwei
    Wang, Shaoming
    Chen, Ru
    Sun, Kexin
    Zeng, Hongmei
    Zhou, Jiachen
    Wei, Wenqiang
    CANCER COMMUNICATIONS, 2021, 41 (11) : 1183 - 1194
  • [22] CANCER INCIDENCE IN NORTH WEST ALGERIA (MASCARA) 2000-2010: RESULTS FROM A POPULATION-BASED CANCER REGISTRY
    Benarba, Bachir
    Meddah, Boumedienne
    Hamdani, Houria
    EXCLI JOURNAL, 2014, 13 : 709 - 723
  • [23] Incidence of prostate cancer in Sri Lanka using cancer registry data and comparisons with the incidence in South Asian men in England
    Ranasinghe, Weranja K. B.
    Sibanda, Thabani
    de Silva, M. V. C.
    Ranasinghe, Tamra I. J.
    Persad, Raj
    BJU INTERNATIONAL, 2011, 108 (8B) : E184 - E189
  • [24] Incidence and mortality of prostate cancer in France: trends between 1978 and 2000
    Bauvin, E
    Remontet, L
    Grosclaude, P
    PROGRES EN UROLOGIE, 2003, 13 (06): : 1334 - 1339
  • [25] Gastric cancer incidence in the Romagna Region of Italy: A spatial and temporal analysis
    Mancini, Silvia
    Ravaioli, Alessandra
    Giuliani, Orietta
    Giorgetti, Stefania
    Falcini, Fabio
    Colamartini, Americo
    Bucchi, Lauro
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (12) : 1076 - 1081
  • [26] Temporal and spatial trends and determinants of aggressive prostate cancer among Black and White men with prostate cancer
    Wang, Ming
    Chi, Guangqing
    Bodovski, Yosef
    Holder, Sheldon L.
    Lengerich, Eugene J.
    Wasserman, Emily
    McDonald, Alicia C.
    CANCER CAUSES & CONTROL, 2020, 31 (01) : 63 - 71
  • [27] Rising Prostate Cancer Incidence in Sub-Saharan Africa: A Trend Analysis of Data from the African Cancer Registry Network
    Seraphin, Tobias P.
    Joko-Fru, Walburga Y.
    Kamate, Bakarou
    Chokunonga, Eric
    Wabinga, Henry
    Somdyala, Nontuthuzelo I. M.
    Manraj, Shyam S.
    Ogunbiyi, Olufemi J.
    Dzamalala, Charles P.
    Finesse, Anne
    Korir, Anne
    N'Da, Guy
    Lorenzoni, Cesaltina
    Liu, Biying
    Kantelhardt, Eva J.
    Parkin, Donald M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (01) : 158 - 165
  • [28] Spatial-temporal analysis of tuberculosis in Chongqing, China 2011-2018
    Yu, Ya
    Wu, Bo
    Wu, Chengguo
    Wang, Qingya
    Hu, Daiyu
    Chen, Wei
    BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [29] Impact of prebiopsy MRI on prostate cancer staging: Results from the Norwegian Prostate Cancer Registry
    Haug, Erik Skaaheim
    Myklebust, Tor Age
    Juliebo-Jones, Patrick
    Reisaeter, Lars Anders Rokne
    Aas, Kirsti
    Berg, Arne Stenrud
    Muller, Christoph
    Hofmann, Bjorn
    Storkersen, Oystein
    Nilsen, Kim L.
    Johannesen, Tom Borge
    Beisland, Christian
    BJUI COMPASS, 2023, 4 (03): : 331 - 338
  • [30] The incidence of prostate cancer in Iran: Results of a population-based cancer registry
    Sadjadi, Alireza
    Nooraie, Mehdi
    Ghorbani, Anahita
    Alimohammadian, Masoomeh
    Zahedi, Mohammad-Javad
    Darvish-Moghadam, Sodeif
    Fakheri, Hafez
    Babai, Masood
    Semnani, Shahriar
    Mansour-Ghanaei, Fariborz
    Mohagheghi, Mohammad-Ali
    ARCHIVES OF IRANIAN MEDICINE, 2007, 10 (04) : 481 - 485